Future fillers | Pocketmags.com
Aesthetic Medicine
Aesthetic Medicine


Future fillers

Platelet Rich Plasma (PRP) is well-established in aesthetic medicine for its growth factordriven regenerative response.

However, it has not been used as a reliable volumisation agent until more recent years, with the advent of new techniques of preparation.

Cellenis® DermaFiller is an autologous, biological filler providing extended-release of platelet-derived growth factors using the slow reabsorption properties of plasmatic proteins. This maintains the renowned efficacy of Cellenis® PRP for a longer time.

The patient’s skin will thrive as it induces collagen formation (to create lift), fibrin (to improve texture) and elastin (to enhance elasticity).

The science and technology behind Cellenis® DermaFiller provides a cutting-edge, novel technique that adds real volume to the face and body.

This is achieved by heating platelet-poor plasma (PPP), which is rich in albumin.

The denaturation and restructure of the proteins provide extended resorption properties lasting up to three to six months. During this time, the biological activity of Cellenis®

DermaFiller enables new tissue formation, providing skin radiance and rejuvenation.

The renowned Cellenis® PRP system lends itself perfectly to the creation of an autologous filler.

• Withdrawal of albumin-rich PPP is simply and efficiently achieved thanks to the unique gel separating technology of Cellenis® PRP

• There are no RBC and minimal inflammatory granulocytes in Cellenis®

PRP plasma, which means no risk that these components are being heated and then reinjected into facial tissue with potential side effects.

Cellenis® DermaFiller has an enhanced safety profile compared to conventional cross-linked Hyaluronic Acid-based fillers, and as an entirely natural autologous biological product, it can be used in most tissue layers without the risks or side effects associated with conventional fillers.

Other major advantages are the almost non-existent probability of immunological or abnormal inflammatory responses as seen with foreign body reactions, granulomatous disease or allergies to other products.

The risk of effects such as the Tyndall effect is also eliminated, particularly in highrisk areas like the tear trough.

Cellenis® DermaFiller provides the best of two worlds. It combines the superior benefits of Cellenis® PRP tissue regeneration efficacy with the immediate and notable filling effect of a protein scaffold to provide a natural soft-tissue augmentation. 

Cellenis® DermaFiller naturally adds volume and lift and rejuvenates the skin at the same time.

Contact Medira Ltd for further information.

Email: info@medira.co.uk or call: 08002 922 014 or 07810 358 815.


This article appears in the July-August 2022 Issue of Aesthetic Medicine

More from this issue

Remote prescribing is not endorsed in “any circumstances”
Metabolic syndrome and the skin
In our follow-up to last month’s article on understanding metabolic syndrome, Balsam Alabassi explores how it impacts skin and what you can do about it
Safeguarding your mental health
Beauty business burnout is real, and so your own self-care has never been more important, writes Safety in Beauty’s resident psychotherapist Alan Madin
Supporting healing
Jennifer Irvine explores how can clients can best recover from non-invasive procedures and the role nutrition plays
T time
Rizvan Batha, superintendent pharmacist at Specialist Pharmacy, on how the thyroid can impact beauty
We speak to Mr Taimur Shoaib about opening his new state-of-the-art clinic in Glasgow in the midst of the pandemic and how things have changed two years on

This article appears in the July-August 2022 Issue of Aesthetic Medicine